Implementing work-related Mental health guidelines in general PRacticE (IMPRovE): a protocol for a hybrid III parallel cluster randomised controlled trial.
General practice
Guideline implementation
Hybrid III trial
Integrated Knowledge Translation
Mental health
Work
Journal
Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411
Informations de publication
Date de publication:
04 08 2021
04 08 2021
Historique:
received:
06
07
2021
accepted:
25
07
2021
entrez:
5
8
2021
pubmed:
6
8
2021
medline:
26
11
2021
Statut:
epublish
Résumé
The Clinical Guideline for the Diagnosis and Management of Work-related Mental Health Conditions in General Practice (the Guideline) was published in 2019. The objective of this trial is to implement the Guideline in general practice. Implementing work-related Mental health conditions in general PRacticE is a hybrid III, parallel cluster randomised controlled trial undertaken in Australia. Its primary aim is to assess the effectiveness of a complex intervention on the implementation of the Guideline in general practice. Secondary aims are to assess patient health and work outcomes, to evaluate the cost-effectiveness of the trial, and to develop a plan for sustainability. A total of 86 GP clusters will be randomly allocated either to the intervention arm, where they will receive a complex intervention comprising academic detailing, enrolment in a community of practice and resources, or to the control arm, where they will not receive the intervention. GP guideline concordance will be assessed at baseline and 9 months using virtual simulated patient scenarios. Patients who meet the eligibility criteria (>18years, employed, and receiving care from a participating GP for a suspected or confirmed work-related mental health condition) will be invited to complete surveys about their health and work participation and provide access to their health service use data. Data on health service use and work participation compensation claim data will be combined with measures of guideline concordance and patient outcomes to inform an economic evaluation. A realist evaluation will be conducted to inform the development of a plan for sustainability. We anticipate that GPs who receive the intervention will have higher guideline concordance than GPs in the control group. We also anticipate that higher concordance will translate to better health and return-to-work outcomes for patients, as well as cost-savings to society. The trial builds on a body of work defining the role of GPs in compensable injury, exploring their concerns, and developing evidence-based guidelines to address them. Implementation of these guidelines has the potential to deliver improvements in GP care, patient health, and return-to-work outcomes. ACTRN12620001163998 , November 2020.
Sections du résumé
BACKGROUND
The Clinical Guideline for the Diagnosis and Management of Work-related Mental Health Conditions in General Practice (the Guideline) was published in 2019. The objective of this trial is to implement the Guideline in general practice.
TRIAL DESIGN
Implementing work-related Mental health conditions in general PRacticE is a hybrid III, parallel cluster randomised controlled trial undertaken in Australia. Its primary aim is to assess the effectiveness of a complex intervention on the implementation of the Guideline in general practice. Secondary aims are to assess patient health and work outcomes, to evaluate the cost-effectiveness of the trial, and to develop a plan for sustainability.
METHODS
A total of 86 GP clusters will be randomly allocated either to the intervention arm, where they will receive a complex intervention comprising academic detailing, enrolment in a community of practice and resources, or to the control arm, where they will not receive the intervention. GP guideline concordance will be assessed at baseline and 9 months using virtual simulated patient scenarios. Patients who meet the eligibility criteria (>18years, employed, and receiving care from a participating GP for a suspected or confirmed work-related mental health condition) will be invited to complete surveys about their health and work participation and provide access to their health service use data. Data on health service use and work participation compensation claim data will be combined with measures of guideline concordance and patient outcomes to inform an economic evaluation. A realist evaluation will be conducted to inform the development of a plan for sustainability.
RESULTS
We anticipate that GPs who receive the intervention will have higher guideline concordance than GPs in the control group. We also anticipate that higher concordance will translate to better health and return-to-work outcomes for patients, as well as cost-savings to society.
CONCLUSIONS
The trial builds on a body of work defining the role of GPs in compensable injury, exploring their concerns, and developing evidence-based guidelines to address them. Implementation of these guidelines has the potential to deliver improvements in GP care, patient health, and return-to-work outcomes.
TRIAL REGISTRATION
ACTRN12620001163998 , November 2020.
Identifiants
pubmed: 34348743
doi: 10.1186/s13012-021-01146-8
pii: 10.1186/s13012-021-01146-8
pmc: PMC8335858
doi:
Banques de données
ANZCTR
['ACTRN12620001163998']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
77Informations de copyright
© 2021. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Implement Sci. 2009 May 21;4:29
pubmed: 19460163
Cochrane Database Syst Rev. 2019 Jun 24;6:CD000125
pubmed: 31232458
J Med Internet Res. 2018 Feb 02;20(2):e34
pubmed: 29396385
JMIR Med Educ. 2016 Aug 18;2(2):e13
pubmed: 27731864
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Curr Diab Rep. 2016 Oct;16(10):98
pubmed: 27586191
Health Res Policy Syst. 2020 Sep 29;18(1):113
pubmed: 32993665
Med Care. 2001 Aug;39(8 Suppl 2):II2-45
pubmed: 11583120
BMC Fam Pract. 2020 Jul 2;21(1):132
pubmed: 32615930
BMC Health Serv Res. 2018 Aug 29;18(1):666
pubmed: 30157844
Aust J Prim Health. 2014;20(3):241-9
pubmed: 23647584
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
BMJ Open. 2016 Jan 20;6(1):e009423
pubmed: 26792215
Implement Sci. 2009 May 17;4:27
pubmed: 19445723
J Occup Rehabil. 2014 Dec;24(4):766-76
pubmed: 24647855
J Occup Rehabil. 2019 Mar;29(1):64-71
pubmed: 29476311
Acad Med. 2018 Feb;93(2):185-191
pubmed: 28746073
Implement Sci. 2018 Jan 25;13(1):21
pubmed: 29370813
Stat Med. 2016 Nov 20;35(26):4718-4728
pubmed: 27350420
Am J Manag Care. 2015 Jan;21(1):75-84
pubmed: 25880152
J Occup Rehabil. 2006 Mar;16(1):41-52
pubmed: 16691458
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Psychiatry Res. 2019 Oct;280:112513
pubmed: 31434011
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
Eur J Haematol. 2018 Apr;100 Suppl 1:5-13
pubmed: 29498784
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Work. 2018;59(3):449-462
pubmed: 29630586
Med J Aust. 2019 Jul;211(2):76-81
pubmed: 31231820
Med Decis Making. 2014 Aug;34(6):773-86
pubmed: 24025661
Can J Psychiatry. 2009 Aug;54(8):534-46
pubmed: 19726006
BMJ Open. 2020 Aug 16;10(8):e037734
pubmed: 32801204
Med J Aust. 2013 Oct 7;199(7):480-3
pubmed: 24099209
J Occup Rehabil. 2016 Sep;26(3):340-9
pubmed: 26615412
J Med Internet Res. 2019 Nov 27;21(11):e14545
pubmed: 31774401
J Pharm Policy Pract. 2018 Aug 1;11:19
pubmed: 30079250
Psychiatry Res. 2015 Feb 28;225(3):291-8
pubmed: 25578983
BMC Fam Pract. 2015 Aug 15;16:100
pubmed: 26275607
Cochrane Database Syst Rev. 2020 Jul 31;8:CD004398
pubmed: 32748975